Marshall Stephen Sussman1,2 and Bernd Juergen Wintersperger1,2
1Medical Imaging, University Health Network, Toronto, ON, Canada, 2Medical Imaging, University of Toronto, Toronto, ON, Canada
Synopsis
The MOLLI $$$T_1$$$ mapping technique has been used to characterize a variety of cardiac pathologies. However, a significant limitation of this technique is the requirement for rest periods between inversion groups. This increases scan time, and limits the choice of possible inversion groups. A new technique, inversion group (IG) MOLLI fitting, has been recently shown to eliminate the requirement for rest periods, and permits complete flexibility of inversion group selection. However, a significant limitation of this technique is that the resulting $$$T_1$$$ maps have low precision. In this study, a method is presented for high precision IG fitting. INTRODUCTION
MOLLI $$$T_1$$$ mapping has been
used extensively to characterize a variety of cardiac pathologies. For effective differentiation of pathology, $$$T_1$$$ maps must be of sufficient
quality to distinguish real changes in $$$T_1$$$
due to pathology, from $$$T_1$$$ variations caused by noise and/or artifacts. However, with conventional MOLLI, $$$T_1$$$ map quality is limited by the requirement
for rest periods between inversion groups. These lengthen breath
hold time, increasing the likelihood of artifacts. They also restrict the amount
and type of data that can be acquired in a given time. This limits our ability to optimize inversion groups
for precision. To
address these shortcomings, the inversion group
(IG) MOLLI $$$T_1$$$-fitting
technique has been developed (1). It does not require rest periods, and permits complete flexibility over inversion groups. However, a limitation of this technique is that
the $$$T_1$$$ maps have low precision. In this study, a method for high precision IG fitting is presented.
THEORY
In conventional MOLLI, $$$T1_1$$$ maps are generated from a 3-parameter fit (2). In IG-MOLLI, a fitting function that is piecewise continuous over the n inversion groups is employed: $$S_i(A,B_1,...,B_n,T_1^*;TI)=A-B\cdot\exp^{-\frac{TI}{T_1^*}};\enspace i=1,..,n \qquad [1]$$
The true $$$T_1$$$ value may be derived as: $$T_1^i=T_1^*\cdot(\frac{B_i}{A}-1)/{\delta_i};\enspace i=1,..,n \qquad [2]$$
where $$$\delta_i$$$ is the inversion factor ($$$\equiv |M_z/M_0|$$$)
following the $$$i^{th}$$$ inversion pulse (3). In the original IG method, Eq. 2 was applied to the first inversion group only, as this was the only one where
$$$\delta_i$$$ is known a priori ($$$\equiv$$$1). We hypothesize that improved precision could be achieved if all data were utilized.
To make use of all available data, we first determine $$$\delta_i$$$ for all n inversion groups: $$\delta_i=\frac{\Sigma_{j\space\epsilon\space Neighbourhood \space Pixels}\space (B_i/A-1)}{\Sigma_{j\space\epsilon\space Neighbourhood \space
Pixels}\space (B_1/A-1)};\enspace i=1,..,n \qquad [3]$$ where the sums are taken over a small neighbourhood surrounding each pixel. We next calculate $$$T_1^i$$$ for each inversion group via Eq. 2. Finally, all data is averaged together into a composite $$$T_1$$$: $$T_1^{composite}=average([T_1^1,...,T_1^n]);\qquad [4]$$
METHODS
Five cardiac patients were scanned (1.5T) with three MOLLI
acquisition schemes: 5(3)3, 5(0)3, and 5(0)3(0)3; where non-bracketed and bracketed numbers indicate inversion groups and rest periods respectively. 5(3)3 is a common scheme used in pre-contrast imaging (4). It is considered the reference standard due to its long rest period. 5(0)3 acquires the same number of TI's, but in three less heartbeats than 5(3)3. 5(0)3(0)3 acquires three more TI's in the same number of heartbeats.
$$$T_1$$$ maps were generated with original- and composite-IG fitting. Additionally, 3-parameter fits were applied to the 5(3)3 data to generate reference $$$T_1$$$ maps. The accuracy of IG fitting was determined by evaluating the discrepancy with the reference. Precision was defined as the standard deviation over a myocardial
ROI. Differences in precision relative to the reference were assessed with a t-test.
RESULTS
Figures 1 and 2 plot the quantitative results for all patients. The mean discrepancy relative to the reference scan is small -- ~1-2%. In terms of precision, all original IG MOLLI data are significantly worse than the reference -- as expected. For the composite IG technique,the 5(3)3 and 5(0)3 $$$T_1$$$ maps have the same precision. Due to the additional TI's, the 5(0)3(0)3 data has significantly better precision than the reference.
Figure 3 illustrates an example of a 5(0)3 acquisition, which acquired the same amount of data in three less heartbeats than the 5(3)3 reference. To appreciate the accuracy of IG fitting, note the conistency of $$$T_1$$$ maps relative to the reference. As expected (1), the precision of the original IG $$$T_1$$$ maps are significantly noisier than the reference. However, the composite IG $$$T_1$$$ maps have a similar precision to the reference.
Figure 4 shows an example of a 5(0)3(0)3 acquisition. As before, the original IG $$$T_1$$$ map has poorer precision than the reference. However, in this case, due to the larger number of TI's acquired, the composite IG $$$T_1$$$ map has better precision than the reference.
CONCLUSIONS
The composite IG $$$T_1$$$ mapping technique combines high precision with complete flexibility of inversion group and rest period selection. This study demonstrated two ways in which these features could be exploited: First, rest periods were eliminated to shorten scan time, whilst maintaining precision. Second, rest periods were replaced with additional data acquisition to achieve better precision in equivalent scan time. Further improvements may be possible with an appropriate optimization of inversion groups and rest periods.
With the improvements demonstrated in this study, we anticipate that composite IG $$$T_1$$$ mapping technique will better discriminate true pathology from artifacts and/or noise than current methods.
Acknowledgements
The authors wish to acknowledge funding support
provided by the Ontario Research Fund (ORF).References
1. Yang IY, et al., ISMRM 2015; 1677
2. Messroghli DR, et al., MRM 2004; 52(1):141-146
3. Kellman P, et al., MRM 2014; 71(4):1428-1434
4. Kellman P, et al., JCMR 2013; 15